Health Technology
The decision to pivot an entire business to focus on the coronavirus is an obvious one in hindsight, at least for Moderna, BioNTech and Pfizer, which succeeded beyond anyone’s expectations — and will reap billions of dollars in sales of their vaccines this year alone.
Credit CNBC
Please support our Sponsors here :